Roche Molecular Systems’ cobas vivoDx MRSA Gets FDA Approval
The US Food and Drug Administration (FDA) has granted marketing approval for Roche Molecular Syste…
The US Food and Drug Administration (FDA) has granted marketing approval for Roche Molecular Syste…
QuantuMDx Group Limited and Ontera, Inc have announced a collaboration to create a next-generation…
A milestone patent for a rapid, automated test for detecting Mycobacterium tuberculosis (TB) and R…
Immunexpress, Inc. announced the U.S. Patent and Trademark Office (USPTO) has granted Patent No. U…
Researchers have developed a user-friendly dengue test that could help diagnose the growing tropic…
T2 Biosystems, Inc., a leader in the development and commercialization of innovative medical diagn…
A group of scientists in Kansas, based at The Agricultural Research Service of the US Department o…
Utilizing a Renishaw Raman spectroscopy system, a team of researchers from the Czech Academy of Sc…
Researchers at IIT Delhi are working on a technology to devise diagnostic solutions for combating …
As associate medical director of clinical immunopathology at the University of Pittsburgh Medical …
The U.S. Food and Drug Administration allowed marketing of a rapid diagnostic test (RDT) to detect…
Researchers at Columbia University have developed a microfluidic device that can diagnose Lyme dis…
Researchers at the University of Warwick have found bacteria can be detected in minutes by zapping…
The fresh food in your grocery stores could eventually get cheaper thanks in part to new technolog…
Mesa Biotech Inc. is a privately-held, molecular diagnostic company that has developed the Accula™…
A combination of off-the-shelf quantum dot nanotechnology and a smartphone camera soon could allow…
Indian Institute of Technology Guwahati Researchers have developed a low-cost, hand-held device to…
Luminex Corporation announced that the company submitted the ARIES® MRSA Assay to the U.S. Food an…
Salmonella and listeria are among the most widely distributed and deadliest causes of foodborne in…
LamdaGen Corporation and Arisan Therapeutics announced today they will share a $2 million Phase II…
A new study has shown a new point-of-care (POC) device to diagnose tuberculosis (TB) in people liv…
Metagenomic next-generation sequencing, or NGS, of cerebrospinal fluid can improve the diagnosis o…
Although the diagnostic performance for all tests were modest in regards to the detection of invas…
Karius, a life sciences company that delivers genomic insights for infectious diseases, announced …